• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LIMITED INFANT DUAL HEATED EVAQUA2 BREATHING CIRCUIT; BZE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LIMITED INFANT DUAL HEATED EVAQUA2 BREATHING CIRCUIT; BZE Back to Search Results
Model Number RT268
Device Problem Use of Device Problem (1670)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/20/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4) pma/510(k) the rt268 infant dual heated evaqua2 breathing circuit is not sold in the usa but it is similar to a product sold in the usa.The 510(k) for that product is k103767.Method: the expiratory limb of the complaint rt268 infant dual heated evaqua2 breathing circuit was returned to fisher and paykel healthcare in (b)(4), and was visually inspected.Results: visual inspection of the returned expiratory limb revealed that it was degraded near the patient end connector.A crack was also observed at the patient end connector's pressure line port.Conclusion: the observed degradation is most likely due to the use of the nebulizing drug alevaire, which contains tyloxapol as an active ingredient.Our user instructions that accompany the rt268 infant dual heated evaqua2 breathing circuit have the warning "do not use medications containing tyloxapol (such as tacholiquin) as this may damage the tubing and lead to a loss of ventilation pressure".It also state the following: "set appropriate ventilator alarms." "perform a pressure and leak test on the breathing system and check for occlusion before connecting to a patient." "do not soak, wash, sterilize, or reuse this product.Avoid contact with chemicals, cleaning agents, or hand sanitizers.".
 
Event Description
A hospital in (b)(6) reported to a distributor that the collar of one of the limbs of an rt268 infant dual heated evaqua2 breathing circuit was found cracked after six days of use.It was also reported that alevaire, which contains tyloxapol as an active ingredient, was used; however, it was stopped few days before the reported damage on the limb was observed.No patient consequence was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFANT DUAL HEATED EVAQUA2 BREATHING CIRCUIT
Type of Device
BZE
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LIMITED
15 maurice paykel place
east tamaki
auckland, auckland 2013
NZ  2013
Manufacturer (Section G)
FISHER & PAYKEL HEALTHCARE LIMITED
15 maurice paykel place
east tamaki
auckland, auckland 2013
NZ   2013
Manufacturer Contact
sharon kuruvilla
173 technology dr., suite 100
irvine
9494534000
MDR Report Key7372198
MDR Text Key103919558
Report Number9611451-2018-00206
Device Sequence Number1
Product Code BZE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
SEE H10
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Other
Type of Report Initial
Report Date 02/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/26/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberRT268
Device Catalogue NumberRT268
Device Lot NumberNOT PROVIDED
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/09/2018
Was the Report Sent to FDA? No
Date Manufacturer Received02/26/2018
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-